RxDoctor Payments Data

Michael Salcedo

Foot & Ankle Surgery · Mishawaka, INNPI 1528065059

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,455 of the $10,259 with a category attached, or 62.9%. 18 manufacturers reported payments, led by Stryker at 36.2% of the total.

$10,259in general payments, 2019–2025

Across 134 payments — averaging $76.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Mimedx Group, Inc.$2K
  • Kerecis Limited$1K
  • Organogenesis Inc.$1K
  • Smith+Nephew$457
  • Johnson & Johnson$225
  • plus $1K from 12 others

What the payments were for

  • Speaking & faculty fees$4695%
  • Travel & lodging$3,33633%
  • Food & beverage$6,45563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,259 in reported general payments places this provider in the 70th percentile of 212 foot & ankle surgery providers in Indiana.

See all foot & ankle surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$109,286
Medicare patients
217
Services billed
1,842

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate42$546
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav51$493
Gabapentin42$484
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$421
Montelukast Sodium12$213
Diclofenac Sodium14$179
Atorvastatin Calcium12$160
Terbinafine Hcl18$147
Levofloxacin20$108
Ciprofloxacin Hcl11$94
Tramadol Hcl21$83
Lisinopril16$47
Allopurinol13$46
Furosemide11$22

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Mishawaka

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →